High-precision bio-compatible implants designed to minimize post-sternotomy sternal dehiscence and optimize bone healing in cardiothoracic procedures.
An engineering and clinical analysis of biomechanical primary stability, bone healing kinetics, and reduction of postoperative complications in median sternotomy procedures.
For decades, stainless steel wire cerclage was the clinical default for post-median sternotomy closure. However, clinical evidence across major healthcare networks in Georgia demonstrates that dynamic thoracic forces—generated by inspiration, expiration, coughing, and lateral upper-body movement—subject the bisected sternum to shear and transverse forces exceeding 1,500 N. Traditional wire closure allows micro-motion, leading to bone cut-through, sternal dehiscence, chronic pain, and deep sternal wound infection (DSWI).
Moventra’s Sternal Fixation System leverages rigid locking titanium plate technology to achieve primary rigid stabilization. By converting shear forces into axial compressive forces, rigid locking plates maintain osteotomy gap contact under 0.1 mm, accelerating primary cortical bone healing. Titanium alloy (Ti-6Al-4V ELI) plates match the modulus of cortical bone more closely than steel, preventing stress shielding while providing superior fatigue resistance.
Analyzing surgical volume growth, healthcare infrastructure modernization, and procurement evolution across cardiothoracic centers.
Worldwide demand for rigid sternal fixation systems is expanding dramatically. Driven by an aging population, rising diabetes incidence, and an increase in complex Coronary Artery Bypass Grafting (CABG) surgeries, cardiothoracic surgical departments worldwide are phasing out wire closure in high-risk cohort profiles. Low-profile titanium locking plates are now considered best-practice interventions in top-tier medical institutions across North America, Europe, and Asia.
Whether supplying major cardiovascular surgery hubs across the State of Georgia (such as Atlanta, Augusta, and Savannah hospital networks) or supporting international healthcare infrastructure in the country of Georgia (Tbilisi medical clusters), Moventra delivers localized supply chain stability. Georgia’s cardiothoracic units demand medical devices that carry rigorous international approvals, cost-effective volume logistics, and immediate surgical instrument availability.
Managing post-sternotomy mediastinitis or dehiscence costs healthcare institutions between $30,000 and $60,000 per patient event. By implementing Moventra’s rigid titanium sternal locking system, hospitals in Georgia achieve substantial long-term cost avoidance. Reduced readmission rates, shorter intensive care unit (ICU) stays, and lower revision surgery frequency significantly optimize hospital operational margins.
High-precision orthopedic manufacturing backed by 13 years of industry expertise, advanced Swiss CNC engineering, and uncompromised quality assurance.
Moventra Medical Technology (China) Co., Ltd. is a professional manufacturer specializing in the research, development, production, and global supply of orthopedic medical devices and surgical solutions. Established in 2017, the company is dedicated to delivering innovative, high-quality products for trauma, spine, joint reconstruction, sports medicine, and orthopedic surgical procedures.
With a modern manufacturing facility covering 18,600 m², Moventra integrates advanced CNC machining, precision manufacturing, automated production lines, and strict quality management systems to ensure every product meets international medical standards. Our commitment to continuous innovation enables us to provide reliable OEM and ODM services for global medical device brands, distributors, and healthcare institutions.
Supported by an experienced R&D team and comprehensive quality assurance system, Moventra continuously develops innovative orthopedic solutions that improve surgical efficiency and patient outcomes. Our products are exported to customers worldwide and are trusted for their precision, safety, and consistent performance.
| Performance Metric / Capability | Enterprise Details & Compliance Specifications |
|---|---|
| Company Name | Moventra Medical Technology (China) Co., Ltd. |
| Brand Identifier | Moventra |
| Year Established | 2017 (13 Years Industry Heritage) |
| Facility Surface Area | 18,600 m² Advanced Cleanroom & Manufacturing Facility |
| Annual Export Revenue | USD 23.8 Million |
| Global Export Experience | 7+ Years Dedicated International Exportation |
| Quality Inspection Protocol | 100% Comprehensive Quality Inspection Prior to Shipment |
| Inspection Methodologies | Dimensional Micro-Inspection, Material Spectroscopy, Surface Roughness Analysis, Mechanical Tensile/Fatigue Testing, Sterility Verification |
| Dedicated QC Staff | 48 Quality Control & Regulatory Specialists |
| Business Model | Manufacturer, Custom OEM & ODM Partner, Global Exporter |
| Primary Target Markets | North America, Europe, South America, Middle East, Southeast Asia, Australia, Georgia (Eurasia / US Regional) |
| Supply Chain Footprint | 1,120 Qualified Global Distribution Partners |
| Client Typologies | Medical Device Brands, Hospital Procurement Directorates, Orthopedic Importers, Government Tenders |
| R&D Engineering Capabilities | Independent FEA Biomechanical Design, Prototyping, OEM/ODM Development, Surgical Instrument Customization |
| Customization Scope | Laser Logo Engraving, Customized Packaging, Drawing-Based Precision Milling, Sample Reverse Engineering |
| R&D Product Pipeline | 156 New Medical Device SKUs Launched Last Year |
| R&D Engineering Personnel | 86 Specialized Biomedical & Mechanical Engineers |
Our 18,600 m² facility features Swiss-type CNC lathes, multi-axis milling machining centers, and micro-coordinate measurement systems.
Tailored cardiothoracic, orthopedic trauma, and reconstructive solutions adapted for diverse patient demographics.
Patients undergoing open-heart surgery with co-morbidities such as severe osteoporosis, Type II diabetes, or obesity present extreme risk for sternal non-union. Moventra’s Star-Type and H-Shaped titanium locking plates provide multi-directional rigid stabilization, eliminating wire slice-through and maintaining sternal compression throughout the 6-week critical healing window.
In severe blunt chest trauma caused by automotive accidents or industrial incidents in Georgia’s urban transport corridors, sternal fracture comminution requires immediate anatomical reduction. Our anatomical low-profile titanium reconstruction plates allow rapid intraoperative contouring, reducing surgical time in level-1 trauma centers.
Complex chest wall deformities and post-oncological thoracic resections demand custom-contoured structural support. Moventra’s Funnel Chest Orthopedic Systems and longitudinal titanium rib plates provide flexible yet durable internal fixation that restores respiratory biomechanics and aesthetic chest contouring.
Driving the future of thoracic trauma engineering through smart materials, additive manufacturing, and bio-integrative surfaces.
Integrating high-resolution patient CT scans into automated CAD/CAM workflows to 3D-print custom, porous titanium lattice sternal implants. This reduces operative fitment time by 40% and enhances direct osseointegration across complex defect sites.
Deployment of anodic osteogenic titanium surface modifications (hydroxyapatite nano-coating with silver ion elution) to eliminate bacterial biofilm formation and accelerate bone cell proliferation at the screw-plate interface.
Researching sub-millimeter Wireless Micro-Electro-Mechanical Systems (MEMS) sensors integrated directly into sternal plates to provide real-time bio-telemetry data regarding sternal stress loads, temperature spikes, and bone healing progression to Georgia clinical teams.
Streamlined international logistics, complete regulatory dossier preparation, and custom OEM branding support.
We supply complete technical documentation packages (including ISO 13485:2016, CE Mark under MDR, bio-compatibility testing reports according to ISO 10993, and mechanical fatigue test results) required for rapid clearance with regulatory bodies in Georgia and international healthcare authorities.
From custom plate thickness alterations and specialized locking screw thread pitches to private-label sterile packaging design, our 86 R&D engineers convert customer specifications or CAD models into market-ready sterile products within rapid turnaround cycles.
Leveraging long-term partnerships with over 1,120 global logistics providers, Moventra guarantees temperature-controlled, shock-monitored air and sea freight delivery direct to hospital central supply departments and regional distributors across Georgia.
Explore our broader range of high-precision orthopedic trauma locking plates, spinal instruments, and surgical tools available for export to Georgia.
Complementary high-performance surgical power systems, osteotomes, and trauma locking plates serving healthcare providers across Georgia.
Expert answers regarding clinical indications, biomechanical properties, regulatory compliance, and export logistics to Georgia.
Enhance cardiothoracic surgical outcomes in Georgia with Moventra’s ISO 13485 certified titanium sternal fixation systems. Contact our biomedical engineering and international trade team today for technical catalogs, CAD samples, or competitive export pricing.
Send Inquiry Now
Moventra Medical
